Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden flag Sweden · Delayed Price · Currency is SEK
11.08
+0.34 (3.17%)
Aug 22, 2025, 5:29 PM CET

Vicore Pharma Holding AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
-370.92-168.63-310.94-288.42-296.48-146.86
Upgrade
Depreciation & Amortization
0.562.243.423.613.63.54
Upgrade
Loss (Gain) From Sale of Assets
---2--
Upgrade
Asset Writedown & Restructuring Costs
--62.55---
Upgrade
Other Operating Activities
41.263.286.033.830.640.71
Upgrade
Change in Accounts Receivable
-28.99-35.6-4.28-1.6-0.34-3.87
Upgrade
Change in Accounts Payable
27.0633.77-6.36-19.3427.4126.55
Upgrade
Operating Cash Flow
-331.04-164.95-249.58-299.92-265.17-119.94
Upgrade
Sale (Purchase) of Intangibles
----3--3
Upgrade
Investment in Securities
-478.88149.04-144.4677-77
Upgrade
Investing Cash Flow
-480.29149.04-144.4674-74
Upgrade
Issuance of Common Stock
882.15882.14500.41200336187.55
Upgrade
Other Financing Activities
-48.08-48.08-29.55-12.96-17.82-10.58
Upgrade
Financing Cash Flow
834.07834.06470.86187.04318.18176.97
Upgrade
Foreign Exchange Rate Adjustments
-29.84.23-1.48-0.43-
Upgrade
Net Cash Flow
-7.05822.3876.82-37.445.5861.03
Upgrade
Free Cash Flow
-331.04-164.95-249.58-299.92-265.17-119.94
Upgrade
Free Cash Flow Margin
-4276.40%-150.85%----
Upgrade
Free Cash Flow Per Share
-1.67-1.21-2.58-4.15-3.81-2.21
Upgrade
Cash Interest Paid
0.040.0100.010.010.01
Upgrade
Levered Free Cash Flow
-240.82-111.57-200.41-195.17-160.92-71.86
Upgrade
Unlevered Free Cash Flow
-215.25-111.56-200.41-195.16-160.92-71.86
Upgrade
Change in Working Capital
-1.94-1.84-10.65-20.9427.0722.68
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.